Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human FRK Stable Cell Line

    [CAT#: S01YF-1123-KX246]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1150 Magic™ Human FRK in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    FRK
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    MDA-MB-231; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cancer Research
    Related Diseases
    Co-Trimoxazole Allergy and Liver Benign Neoplasm. Among its related pathways are PIP3 activates AKT signaling and Innate Immune System
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Encoded by the FRK gene in humans, fyn-related kinase (FRK, previously tyrosine protein kinase 5) is an enzyme. The TYR family of protein kinases includes the protein that this gene encodes. This nuclear protein tyrosine kinase may inhibit growth during the G1 and S phases of the cell cycle. Following its initial discovery in 1993, research on FRK suggested that the enzyme may have a tumor-suppressive role. Additional functional analysis of the tyrosine kinase in many cancer types implies that FRK might also be carcinogenic. In particular, knockdown or catalytic inhibition of FRK inhibits key cellular activities in pancreatic and brain malignancies, whereas ectopic expression of FRK decreases cell proliferation and migration in breast and liver cancer. The customized FRK stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Anthony

    The affinity is very good and I definitely recommend this FRK cell line. May 27 2021

    chat Verified Customer

    chat Richard

    We are satisfied with this FRK cell line and we will use it in our experimental projects. Jan 01 2020

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Effect of FRK expression on cell proliferation and anchorage-independent growth.

    MDA-MB-231 cells were retrovirally infected with vectors encoding either FRK Y497F (FRK-YF) or wild-type FRK (FRK-WT), from which monoclonal populations were generated and named accordingly. Through quantitative RT-PCR analysis, the expression of FRK mRNA in the designated stable cell lines was ascertained.

    Ref: Ogunbolude, Yetunde, et al. "FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition." Oncotarget 8.68 (2017): 113034.

    Pubmed: 29348886

    DOI: 10.18632/oncotarget.22958

    Research Highlights

    Fyn-related kinase (FRK), a non-receptor tyrosine kinase, belongs to the BRK family of kinases (BFKs) and shares a distant relationship with the Src family of kinases (SFKs).
    Goel, Raghuveera Kumar, and Kiven Erique Lukong. "Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology." Cancer and Metastasis Reviews 35 (2016): 179-199.
    Pubmed: 27067725   DOI: 10.1007/s10555-016-9623-3

    By stimulating metabolic reprogramming, which ultimately encourages EMT and metastasis, FRK enhances the stemness of H1299 cells and hence plays an oncogenic function in lung cancer cells.
    Zhang, Li, et al. "FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming." International Journal of Cancer 146.1 (2020): 208-222.
    Pubmed: 31251822   DOI: 10.1002/ijc.32530

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare